
|Articles|March 1, 2017
- Pharmaceutical Executive-03-01-2017
- Volume 37
- Issue 3
Pharmaceutical Executive, March 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Big Data: Is It Crunch Time for Pharma?over 8 years ago
Setting Sights on the Smart Supply Chainover 8 years ago
Global Pharma Deals with US Trade Overhaulsover 8 years ago
Precision Medicine and Big Dataover 8 years ago
Country Report: IrelandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly to Submit Oral GLP-1 for FDA Priority Review Program: Report
2
GCC Emerges as a New Strategic Anchor for Global Venture Capital
3
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
4
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
5





